Literature DB >> 2147858

Tumour scanning with indium-111 dihaematoporphyrin ether.

M R Quastel1, A M Richter, J G Levy.   

Abstract

Photofrin II (dihaematoporphyrin ether/ester, DHE) was labelled with indium-111 and its biodistribution in tumour bearing mice compared with that of 111In chloride. The uptake and clearance of 111In labelled DHE differed markedly from that of indium-111 chloride in that the former was not taken up by the tissues as much as the latter. Scintillation scanning with a gamma-camera showed marked uptake of both 111In agents at the site of the tumour, but a much lower tissue background (excluding the abdominal organs) for the mice given 111In DHE. Tumour:muscle ratios of dissected tissues were 2-3 times higher in 111In DHE treated animals as compared to the uptake of 111In chloride. There was a distinct difference in the pattern of distribution of the two 111In preparations in the tissues. The major accumulation of 111In chloride was in the kidneys, whereas the highest uptake of 111In DHE was in the liver, the organ in which unlabelled porphyrins accumulate. Extraction and testing of materials from tumours of 111In DHE treated animals indicated that most of the tumour extractable 111In had remained associated with the porphyrin in vivo up to 4 days after injection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147858      PMCID: PMC1971587          DOI: 10.1038/bjc.1990.403

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

Review 2.  Photosensitizers: therapy and detection of malignant tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-06       Impact factor: 3.421

3.  Proposed structure of the tumor-localizing fraction of HPD (hematoporphyrin derivative).

Authors:  D Kessel
Journal:  Photochem Photobiol       Date:  1986-08       Impact factor: 3.421

4.  Binding of trace amounts of ionic indium-113m to plasma transferrin.

Authors:  F Hosain; P A McIntyre; K Poulose; H S Stern; H N Wagner
Journal:  Clin Chim Acta       Date:  1969-04       Impact factor: 3.786

5.  Interaction of human serum low density lipoproteins with porphyrins: a spectroscopic and photochemical study.

Authors:  J P Reyftmann; P Morliere; S Goldstein; R Satus; L Dubertret; D Lagrange
Journal:  Photochem Photobiol       Date:  1984-12       Impact factor: 3.421

6.  Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism.

Authors:  D Gal; P C MacDonald; J C Porter; E R Simpson
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

7.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

Authors:  C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

8.  In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice.

Authors:  G Norata; G Canti; L Ricci; A Nicolin; E Trezzi; A L Catapano
Journal:  Cancer Lett       Date:  1984-12       Impact factor: 8.679

9.  Characterization of intra-tumoral porphyrin following injection of hematoporphyrin derivative or its purified component.

Authors:  T J Dougherty; T S Mang
Journal:  Photochem Photobiol       Date:  1987-07       Impact factor: 3.421

10.  Synthetic porphyrins as tumour-localizing agents.

Authors:  G D Zanelli; A C Kaelin
Journal:  Br J Radiol       Date:  1981-05       Impact factor: 3.039

View more
  2 in total

1.  Development of (111)In-labeled porphyrins for SPECT imaging.

Authors:  Shaghayegh Sadeghi; Mohammad Mirzaei; Mohammad Rahimi; Amir R Jalilian
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

Review 2.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.